glp 1 needle GLP-1 Pills vs. Injections: Weight Loss Data Facts About Compounded GLP-1 Drugs
Description
A recent analysis of over 50 million insured lives found that GLP-1 users experienced 44% fewer hospitalizations for major cardiovascular events, and healthcare spending rose at just half the rate of similar non-users by year two
A BMI of 30 in a white individual carries equivalent diabetes risk to a BMI of approximately 23.9 in a South Asian individual and 26.9 in a Chinese individual
doi: 10.1210/jc.2018-01176
Kleinridders A, Ferris HA, Cai W, Kahn CR
BPI LABS: THE HIMS SUPPLIERS SHADY HISTORY The company that makes GLP-1 knockoffs for Hims is BPI, a wholly owned subsidiary of Florida-based Belcher Pharmaceuticals
Liraglutide (Victoza) injection [package insert]
